when fda approve compass pathways comp360 psilocybin
Before July 2027
when fda approve compass pathways comp360 psilocybin. Best Yes near 86¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 86¢ · Best No: 21¢ · 1 platform
- Kalshi: Yes 86¢ / No 21¢
TRADING OPEN
Before July 2027
Volume
$8.6K
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Jun 30, 2027
~289 days left
Category
Culture
Yes
86¢
Kalshi
No
21¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.
Market Details
ResolutionResolves Jun 30, 2027
Time Left289 days
Status● Active
CategoryCulture
Yes
86¢
Kalshi
Payout 1.2x
No
21¢
Kalshi
Payout 4.8x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In